MAPT and spinocerebellar ataxia type 6: Potential biomarkers including glial fibrillary acidic protein, DJ-1, and tau have been studied in SCA1, SCA2, and SCA6 patients, where only CSF tau was significantly higher in patients than controls, though levels did not correlate with CAG repeat size and disease severity [9].